NovoCure Ltd’s recent filing unveils that its Officer MUKUND PARAVASTHU acquired Company’s shares for reported $57788.0 on Jan 13 ’25. In the deal valued at $26.75 per share,2,160 shares were bought.
Then, WILHELMUS C. GROENHUYSEN bought 266,085 shares, generating $7,929,333 in total proceeds.
Before that, Paravasthu Mukund sold 44 shares. NovoCure Ltd shares valued at $734 were divested by the Chief Operating Officer at a price of $16.69 per share. As a result of the transaction, Paravasthu Mukund now holds 3,459 shares, worth roughly $90729.57.
Evercore ISI upgraded its NovoCure Ltd [NVCR] rating to an Outperform from a an In-line in a research note published on December 02, 2024; the price target was increased to $30 from $18. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in mid October from “a Neutral” to “a Buy”. H.C. Wainwright revised its rating on August 28, 2023. It rated NVCR as “a Neutral” which previously was an “a Buy”.
Price Performance Review of NVCR
On Tuesday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -4.18% to $26.23. Over the last five days, the stock has lost -11.56%. NovoCure Ltd shares have fallen nearly -11.98% since the year began. Nevertheless, the stocks have risen 93.72% over the past one year. While a 52-week high of $34.13 was reached on 01/02/25, a 52-week low of $11.70 was recorded on 01/14/25. SMA at 50 days reached $24.62, while 200 days put it at $19.34.
Levels Of Support And Resistance For NVCR Stock
The 24-hour chart illustrates a support level at 25.72, which if violated will result in even more drops to 25.21. On the upside, there is a resistance level at 27.17. A further resistance level may holdings at 28.10. The Relative Strength Index (RSI) on the 14-day chart is 41.46, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.63%. Stochastics %K at 8.03% indicates the stock is a buying.
How much short interest is there in NovoCure Ltd?
A steep rise in short interest was recorded in NovoCure Ltd stocks on 2024-12-31, dropping by -0.24 million shares to a total of 5.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 5.63 million shares. There was a decline of -4.39%, which implies that there is a negative sentiment for the stock.
